Aprecia Pharmaceuticals Co — Form D

Aprecia Pharmaceuticals Co of LANGHORNE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2012-11-19. The offering totals $8.6M, of which $4.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
E Thomas AringtonExecutive OfficerMason, OH
Lawrence Thomas GlassmannExecutive OfficerBlue Ash, OH
Michael S KingExecutive OfficerPrinceton, NJ
Glenn S VraniakExecutive OfficerManalapan, NJ
Michael KingExecutive OfficerROAD TOWN, TORTOLA, D8
Etienne Thomas PeroldDirectorPennington, NJ
Michael Thomas RolhfsExecutive OfficerBlue Ash, OH
David Thomas FurnissExecutive OfficerMason, OH
Robert Thomas WillifordExecutive OfficerBlue Ash, OH
James Thomas EvansDirectorCincinnati, OH
Lawrence Thomas GlassmannDirectorBlue Ash, OH
E Thomas AringtonDirectorMason, OH
Donald Thomas WetherholdExecutive OfficerBlue Ash, OH
Jonathan Thomas LeffDirectorNew York, NY
Michael Thomas RohlfsExecutive OfficerWest Chester, OH
DAVID A FURNISSExecutive OfficerCINCINNATI, OH
ROBERT A WILLIFORDExecutive OfficerCINCINNATI, OH
MICHAEL A ROHLFSExecutive OfficerWEST CHESTER, OH
Etienne A PeroldDirectorPennington, NJ
Etienne A PeroldExecutive OfficerPennington, NJ
DONALD A WETHERHOLDExecutive OfficerLOVELAND, OH
Donald C MonkhouseExecutive OfficerRadnor, PA
Don S WetherholdExecutive OfficerLoveland, OH
Michael C KingExecutive OfficerPrinceton, NJ
Lawrence C GlassmannDirectorCincinnati, OH

Other filings by this issuer (11)

FiledFormOfferingSold
2016-01-28D$84.0M$79.0M
2015-08-31D$52.0M$38.8M
2013-12-10D/A$36.3M$14.9M
2013-12-09D$36.2M$14.9M
2011-11-04D$25.7M$25.7M
2010-12-20D/A$4.9M$3.9M
2010-11-08D/A$455K$455K
2010-10-18D$105K$105K
2010-01-25D/A$5.5M$5.5M
2009-12-24D$2.5M$2.5M
2009-05-29D$500K$500K

More